Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023241 (
Legionella
)
6,990
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Objective:
Legionella
is a waterborne pathogen that causes a severe form of pneumonia called Legionnaires' diseases, which is normally acquired by inhalation of aerosols containing
Legionella
originating from natural and man-made water systems. The aim of this study was to describe the level of antimicrobial susceptibility of environmental
Legionella
spp. strains to preferred and recommended therapeutic agents to treat
Legionella
disease.
Methods:
The minimum inhibitory concentrations (MICs) of 60 environmental
Legionella
spp. strains were tested using the broth dilution method. Susceptibility testing was performed for 12 antimicrobial agents: macrolides (erythromycin, azithromycin [AZI], and clarithromycin [
CLA
]), fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin, and gemifloxacin), a ketolide (telithromycin), cefotaxime (CEF), tigecycline (TIG), doxycycline (DOX), and rifampicin (RIF).
Results:
All tested strains of
Legionella
spp. were inhibited by low concentrations of fluoroquinolones and macrolides. Regarding the macrolides,
CLA
was the most active antibiotic, and AZI was the least active. RIF was the most effective antibiotic against the isolates
in vitro
. All isolates were inhibited by the following antibiotics (in decreasing order of their MICs): DOX>CEF>TIG.
Conclusions:
No resistance against these drugs was detected, and all isolates were inhibited by low concentrations of the tested antibiotics. Susceptibility testing of environmental
Legionella
spp. isolates must be monitored often to detect and evaluate the possible development of antibiotic resistance.
...
PMID:Antimicrobial Susceptibility Patterns of
Legionella
spp. Strains Isolated from Water Systems in Morocco. 3212 20